TrialBritish journal of cancer2019

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes.

Hervé Bonnefoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.